These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12161903)

  • 21. SPECT and PET imaging of brain tumors.
    Hustinx R; Alavi A
    Neuroimaging Clin N Am; 1999 Nov; 9(4):751-66. PubMed ID: 10517943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in tracer techniques, including use of positron emission tomography.
    Young VR; Borgonha S; Ajami AM
    Diabetes Nutr Metab; 2000 Feb; 13(1):35-45. PubMed ID: 10824722
    [No Abstract]   [Full Text] [Related]  

  • 23. [PET study of cholinergic system in the brain].
    Shinotoh H
    Rinsho Shinkeigaku; 1999 Jan; 39(1):33-5. PubMed ID: 10377794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral muscarinic receptors in primary degenerative dementia as evaluated by SPECT with iodine-123-labeled QNB.
    Weinberger DR; Mann U; Gibson RE; Coppola R; Jones DW; Braun AR; Berman KF; Sunderland T; Reba RC; Chase TN
    Adv Neurol; 1990; 51():147-50. PubMed ID: 2294653
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia.
    Testa HJ; Snowden JS; Neary D; Shields RA; Burjan AW; Prescott MC; Northen B; Goulding P
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S123-6. PubMed ID: 3263978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography in dementia.
    Santens P; Petit H
    Acta Neurol Belg; 1997 Sep; 97(3):192-5. PubMed ID: 9345592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical imaging of dementias.
    Minoshima S; Frey KA; Cross DJ; Kuhl DE
    Semin Nucl Med; 2004 Jan; 34(1):70-82. PubMed ID: 14735460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of positron emission tomography data for cerebral atrophy.
    Herscovitch P; Auchus AP; Gado M; Chi D; Raichle ME
    J Cereb Blood Flow Metab; 1986 Feb; 6(1):120-4. PubMed ID: 3484745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
    Silverman DH; Phelps ME
    J Nucl Med; 2000 Nov; 41(11):1929-32. PubMed ID: 11079506
    [No Abstract]   [Full Text] [Related]  

  • 30. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral blood flow and other physiological variables measured by positron emission tomography.
    Legg NJ
    Br J Clin Pract Suppl; 1985 Jun; 39():25-7. PubMed ID: 3929812
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical objectives, tracer constraints and technological requirements for in vivo imaging.
    Jones T
    Med Prog Technol; 1991; 17(3-4):211-8. PubMed ID: 1839852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclotrons and radiopharmaceuticals in positron emission tomography. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel.
    JAMA; 1988 Mar; 259(12):1854-60. PubMed ID: 3278157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.
    Waragai M; Yamada T; Matsuda H
    J Neurol Sci; 2007 Sep; 260(1-2):57-64. PubMed ID: 17493637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.
    Brunetti A; Berg G; Di Chiro G; Cohen RM; Yarchoan R; Pizzo PA; Broder S; Eddy J; Fulham MJ; Finn RD
    J Nucl Med; 1989 May; 30(5):581-90. PubMed ID: 2785582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biokinetics of radioactive tracers: reappraisal of various concepts in the light of positron emission tomography].
    Depresseux JC
    Ann Radiol (Paris); 1984 Dec; 27(8):702-7. PubMed ID: 6335636
    [No Abstract]   [Full Text] [Related]  

  • 37. Positron emission tomography: measurement of the activity of second messenger systems.
    Imahori Y; Fujii R; Tujino H; Kimura M; Mineura K
    Methods; 2002 Jul; 27(3):251-62. PubMed ID: 12183114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White matter hyperintensities and neurodegenerative dementias.
    Sassi C
    Aging (Albany NY); 2019 May; 11(10):2912-2913. PubMed ID: 31102504
    [No Abstract]   [Full Text] [Related]  

  • 39. [F-18 FDG PET in dementia].
    Ichiya Y
    Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical applications of single photon emission tomography in neurology. 2. Dementia, psychoses, inflammation, skull and brain injuries].
    Bartenstein P; Grünwald F; Kuwert T; Tatsch K; Sabri O; Benkert O; Fahlbusch R; Gründer G; Herholz K; Weiller C
    Nuklearmedizin; 2000 Dec; 39(8):218-32. PubMed ID: 11189899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.